title: Cytologically malignant margins of wedge resected stage I non-small cell lung cancer.
abstract: BACKGROUND
  We have developed a novel test for the surgical margin of pulmonary malignant tumor using a cytologic technique (the run-across method in which a glass slide is run across the staple site), and we have assessed whether this method is useful in predicting margin relapse and prognosis.
  
  
  METHODS
  From April 1996 to March 1999, 15 lesions of stage I non-small cell lung cancer (NSCLC) (maximum diameter ranged from 10 to 35 mm with a median of 20 mm) from 15 patients with cardiopulmonary impairment were excised without additional proximal resections. The surgical margin was examined using the run-across method. There were 8 male 7 female patients whose ages ranged from 51 to 80 years. One patient underwent video-assisted thoracic surgery and 14 underwent thoracotomy. The preoperative diagnoses of the patients were 13 adenocarcinomas, 2 squamous cell carcinomas, and 1 undiagnosed lesion (1 adenocarcinoma). The follow-up period ranged from 37 to 63 months.
  
  
  RESULTS
  The rate of positive cytology was 47% in comparison with the rate of positive histology of 20%. There were 4 patients with margin relapse (3 of them contained negative histology margins) at a rate of 57% among the positive cytology patients in comparison with 0% among the negative cytology patients (p = 0.03). In a comparison of survival between the negative cytology group and the positive cytology group, there were no statistically significant differences.
  
  
  CONCLUSIONS
  The run-across method is also useful in confirming complete resection. A positive cytology margin could lead to margin relapse even if a non-small cell lung cancer is resected with a negative histology margin.
authors.affiliation: Division of Surgery, Clinical Pathology, Toneyama National Hospital, Toyonaka, Osaka, Japan. nori@toneyama.hosp.go.jp
authors.forename: Noriyoshi
authors.initials: N
authors.lastname: Sawabata
authors.forename: Akihide
authors.initials: A
authors.lastname: Matsumura
authors.forename: Mitsunori
authors.initials: M
authors.lastname: Ohota
authors.forename: Hajime
authors.initials: H
authors.lastname: Maeda
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Hirano
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Nakagawa
authors.forename: Hikaru
authors.initials: H
authors.lastname: Matsuda
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000601:surgery; D000368:Aged; D000369:Aged, 80 and over; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology* / Q000601:surgery*; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000601:surgery; D003584:Cytological Techniques; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D020775:Thoracic Surgery, Video-Assisted; D013908:Thoracotomy